
Recent European supply chain due diligence laws, such as the Germany’s Act on Corporate Due Diligence Obligations in Supply Chains (LkSG) and EU’s Corporate Sustainability Due Diligence Directive, are now setting more perspective requirements for supply chain responsibility, says Pete Rau, vice president of solution consulting at EcoVadis, a provider of business sustainability ratings.
“We believe these new regulations are a good sign for levelling the playing field and raising everyone’s game and should apply to pharma companies as they would any other industry,” he says.
Read more...
About the Author
EcoVadis is a purpose-driven company dedicated to embedding sustainability intelligence into every business decision worldwide. With global, trusted and actionable ratings, businesses of all sizes rely on EcoVadis’ detailed insights to comply with ESG regulations, reduce GHG emissions, and improve the sustainability performance of their business and value chain across 220 industries in 180 countries. Leaders like Johnson & Johnson, L’Oréal, Unilever, Bridgestone, BASF and JPMorgan are among 150,000+ businesses that use EcoVadis ratings, risk, and carbon management tools and e-learning platform to accelerate their journey toward resilience, sustainable growth and positive impact worldwide.
Follow on Linkedin
Visit Website
More Content by EcoVadis EN